Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2022-10-12 00:00:00 ET · period of report 2022-10-10 · accession 0000899243-22-033509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-12 | 2022-10-10+ | DNA | Kelly Jason R | See Remarks, Dir | S - Sale | $2.88 | -414.0K | 25.80M | -2% | -$1.19M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-10-10 | S | D | 213,575 | $2.88 | 25,999,150 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-10-11 | S | D | 200,435 | $2.87 | 25,798,715 | D | — | — |